Amit Etkin — SPARQNOW

At-a-Glance

Founder and CEO at Alto Neuroscience (NYSE: ANRO), a clinical-stage biopharmaceutical company
Professor (Psychiatry) at Stanford University
Pioneers a precision psychiatry approach to drug development for mental health conditions
Received the NIH Director's Pioneer Award, the first in clinical psychiatry
Ranked in the top 0.1% of researchers by citations

Biography

Amit Etkin is the Founder and CEO of Alto Neuroscience, a clinical-stage biopharmaceutical company listed on the NYSE as ANRO. Alto Neuroscience focuses on integrating patient biology into drug development to improve treatments for mental health conditions. The company currently has four drugs in mid to late-stage clinical trials, utilizing biomarkers to identify likely treatment responders.